NEUROSTAT
Live / Registered — Registered and renewed (as of 14 Nov 2023)
What this means for you
Registered since 04 Jun 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Jun 2023).
Record
- Serial number
- 85555773
- Registration number
- 4347704
- Mark type
- Stylized text
- Filed
- 29 Feb 2012
- Published for opposition
- 17 Jul 2012
- Registered
- 04 Jun 2013
- Next maintenance due
- 04 Jun 2023
- Attorney of record
- Michael B. Chesal
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroke, traumatic brain or spinal cord injury, and other acute or chronic neurological and neurosurgical conditions
Owner
- PHARMING INTELLECTUAL PROPERTY B.V., LEIDEN, NL
- ABLIVA AB, LUND, SE
- NeuroVive Pharmaceutical AB, Lund, SE
- NeuroVive Pharmaceutical AB, Lund, SE
- NeuroVive Pharmaceutical AB, Lund, SE
Prosecution history
- 01 Apr 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 29 Mar 2026 — TEAS SECTION 7 REQUEST RECEIVED
- 14 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Nov 2023 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 Nov 2023 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 08 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 May 2023 — TEAS SECTION 8 & 9 RECEIVED
- 26 Apr 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Jun 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 18 Dec 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 18 Dec 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 06 Dec 2019 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 14 Jun 2019 — POST REGISTRATION ACTION MAILED - SEC. 8
- 14 Jun 2019 — POST REGISTRATION ACTION CORRECTION
- 13 Jun 2019 — POST REGISTRATION ACTION MAILED - SEC. 8